3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride is a high-purity catalysts-auxiliary-agent supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.

1. Pharmaceutical Intermediates

The primary and most important use of this compound is as an intermediate in drug discovery and pharmaceutical synthesis.

Lead Scaffold for Drug Development:

The triazolopyrazine core is a privileged structure used in kinase inhibitors and other targeted therapeutics. The trifluoromethyl substitution enhances its metabolic stability and bioavailability.

Intermediate for Anticancer Agents:

Triazolopyrazine derivatives, especially with a CF₃ group, are often precursors in the synthesis of tyrosine kinase inhibitors (e.g., analogs of imatinib or sorafenib) or antitumor molecules acting on PI3K, Akt, or mTOR pathways.

Central Nervous System (CNS) Drug Development:

The compound may be used in the synthesis of small molecules targeting CNS receptors or enzymes due to its favorable lipophilicity and ability to cross the blood-brain barrier.

2. Agrochemical Intermediate

This compound may serve as a key building block for the synthesis of pesticides or fungicides due to the presence of the trifluoromethyl group and heterocyclic nitrogen atoms, which are known to contribute to biological activity in crop protection products.

Potential to be used in research for developing new insecticidal or fungicidal agents.

Can help enhance pesticide selectivity and environmental stability.

3. Chemical Research & Molecular Probe Development

Used in SAR (Structure-Activity Relationship) Studies:

It is widely applied in medicinal chemistry labs for generating libraries of small molecules with improved activity, selectivity, and pharmacokinetic profiles.

Fragment-Based Drug Design (FBDD):

Its small size, solubility, and reactive scaffold make it suitable for fragment screening and optimization during early-stage drug design.

1. Favorable Pharmacokinetic Properties

The trifluoromethyl group (-CF₃) significantly improves:

Lipophilicity, which supports membrane permeability.

Metabolic stability, making the compound resistant to rapid hepatic degradation.

Bioavailability, particularly in oral formulations.

The hydrochloride salt form enhances aqueous solubility and ensures better handling in formulation development and analytical testing.

2. Versatility of the Triazolopyrazine Core

The triazolopyrazine scaffold is found in many biologically active compounds, such as:

Antimicrobial agents

Kinase inhibitors

CNS-active compounds

Its nitrogen-rich heterocycle configuration increases binding potential to protein targets, enzymes, and receptors.

3. Synthetic Accessibility and Functionalization

This compound offers multiple points of functionalization, allowing chemists to design diverse analogs by modifying positions on the ring or introducing side chains.

Useful for combinatorial synthesis in the development of compound libraries for high-throughput screening (HTS).

4. Chemical Stability

The presence of a trifluoromethyl group improves thermal and chemical stability, which is crucial for long-term storage and handling in lab environments.

Hydrochloride salt increases crystalline purity and reduces hygroscopicity, aiding in consistent synthesis and formulation.

5. Emerging Role in Targeted Therapy Research

As targeted therapies gain prominence in cancer and chronic disease treatment, this compound's structural features (especially the fused ring and CF₃ group) are aligned with design principles for selective and potent enzyme or receptor modulators.

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride (CAS 762240-92-6) is a valuable intermediate in the synthesis of pharmaceutical and agrochemical compounds. Its heterocyclic scaffold, trifluoromethyl group, and salt form confer a range of physicochemical and biological advantages, including improved bioavailability, stability, and binding affinity.

Previous

Diallyldimethylammonium Chloride丨CAS 7398-69-8

Next

Hydrogenated Tallowamine丨CAS 61788-45-2